Filing metadata

Accession number
0001209191-23-024879
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Apr 19, 2023
Reporting period
Apr 17, 2023
Description
Insider transaction

Explore SEC Filings Hub